Johnson & Johnson said Wednesday that it has ended a late-stage trial for its experimental HIV vaccine after data showed the shot was ineffective at preventing infections.
The experimental HIV vaccine that was tested among gay men and transgender people was found to be safe but offered no additional protection against HIV infection compared to a placebo, an independent data and safety monitoring board determined."For our research partners and others who have waged a decadeslong effort to develop vaccines to end the HIV/AIDS pandemic, these results are disappointing," said Susan Buchbinder, co-chairwoman of the clinical trial, known as the Mosaico study.
The global clinical trial recruited nearly 4,000 volunteers from 18 to 60 years old in Europe, North America, and South America and received funding support from the National Institute of Allergy and Infectious Diseases. Researchers had hoped the vaccine could provide broad protection against a variety of HIV strains, using the same antigen delivery system that Johnson & Johnson uses in its COVID-19 vaccine. Its failure is the latest in a field of research that has been wrought with setbacks.
In 2021, a similar vaccine regimen sponsored by Johnson & Johnson and others was found to be ineffective in protecting against HIV infection in a trial in sub-Saharan Africa among young women. Other vaccine candidates being developed by Moderna, NIAID, and the HIV Vaccine Trials Network are still being tested.The World Health Organization said that HIV continues to be a"major global public health issue" that has no cure, though access to treatments, diagnoses, and care has gone up.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
PolitiFact - Magic Johnson did not contract HIV from a contaminated vaccineJudy Mikovitz, a controversial virologist responsible for anti-vaccine conspiracies, claimed that Magic Johnson contracted HIV in 1991 from a contaminated Hepatitis B vaccine. That’s wildly untrue.
Les mer »
J&J to discontinue HIV vaccine trialJohnson & Johnson said on Wednesday that it was pulling the plug on a late-stage global trial of an HIV vaccine after the shot was found ineffective at preventing infections.
Les mer »
Johnson & Johnson slashes production on COVID vaccine amid drop in demandThere were high hopes for J&J's single-dose shot. But now the company is cutting down on production.
Les mer »
Johnson & Johnson slashes production of COVID vaccine amid drop in demandThere were high hopes for J&J's single-dose shot. But now the company is cutting down on production.
Les mer »
J&J’s HIV vaccine fails Phase 3 clinical trialJohnson & Johnson’s experimental HIV vaccine is safe but not effective, and the late-stage study will be discontinued as a result of that finding, federal...
Les mer »
Global Push to Treat HIV Leaves Children BehindAWENDO, Kenya — The stories the mothers tell when they gather at the Awendo Health Centre in western Kenya are a catalog of small failures, missed opportunities and devastating consequences. What unites the two dozen or so women who meet periodically, on wooden benches in a bare clinic room or under a tree in the courtyard, is their children: All have HIV. It has been two decades since efforts to prevent the transmission of HIV, the virus that causes AIDS, from mother to child during pregnancy a
Les mer »